Login / Signup
Biologic disease-modifying anti-rheumatic drugs and kinase inhibitors: differences in efficacy and safety in rheumatoid arthritis.
Roy M Fleischmann
Published in:
Clinical rheumatology (2021)
Keyphrases
</>
rheumatoid arthritis
disease activity
interstitial lung disease
ankylosing spondylitis